TrialDiabetes, obesity & metabolism2019

Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open-label, blinded-endpoint, randomized controlled study (PRIME-V study).

Masaya Koshizaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.